Literature DB >> 17001067

Statin and cancer risks: from tasseomancy of epidemiologic studies to meta-analyses.

Kyungmann Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17001067     DOI： 10.1200/JCO.2006.07.9673

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Nutrition and metabolism in hepatocellular carcinoma.

Authors:  Robert J Smith
Journal:  Hepatobiliary Surg Nutr       Date:  2013-04       Impact factor: 7.293

Review 2.  Statins: do they have a potential role in cancer prevention and modifying cancer-related outcomes?

Authors:  Stefanos Bonovas
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

3.  Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites.

Authors:  David G Menter; Victoria P Ramsauer; Sam Harirforoosh; Kanishka Chakraborty; Peiying Yang; Linda Hsi; Robert A Newman; Koyamangalath Krishnan
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

4.  Cancer symptom control trials: how may we advance this field?

Authors:  N Macdonald
Journal:  Curr Oncol       Date:  2007-06       Impact factor: 3.677

5.  Simvastatin reduces melanoma progression in a murine model.

Authors:  Mario Zanfardino; Carmine Spampanato; Rosanna De Cicco; Elisabetta Buommino; Anna De Filippis; Salvatore Baiano; Adriano Barra; Franco Morelli
Journal:  Int J Oncol       Date:  2013-10-04       Impact factor: 5.650
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.